--- a
+++ b/clusters/3009knumclusters/clust_109.txt
@@ -0,0 +1,805 @@
+Non-pregnant and non-lactating
+Pregnant or lactating patients
+Female patients who are pregnant and/or lactating are not eligible
+Patients who are pregnant or lactating will not be eligible; pregnant patients are ineligible
+Participants who are pregnant or lactating
+Pregnant or lactating women
+Is pregnant or lactating
+Pregnant, lactating, or planning to become pregnant during the study and up to 3 months after last dose of study drug
+Pregnant or lactating women
+Women who are pregnant or lactating.
+Pregnant or lactating
+Women who are pregnant or lactating
+Women who are pregnant or lactating
+Not pregnant or lactating, willing to prevent pregnancy while on study and for 6 months after the last dose of XMT-1522
+Pregnant or lactating females
+Currently pregnant or lactating
+Subject is pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating females
+Pregnant or lactating women
+Women who are pregnant or lactating (breastfeeding)
+Female subjects who are both lactating and breastfeeding
+Female subjects who are pregnant or lactating.
+Pregnant or lactating females.
+Women who are pregnant or lactating
+Lactating or pregnant woman
+Pregnant or lactating females
+Pregnant or lactating female
+Pregnant or lactating females
+Pregnant or lactating women
+Pregnant or lactating women
+Patient is pregnant or lactating.
+Pregnant or lactating females are excluded
+Pregnant or lactating females
+Pregnant or lactating females
+Pregnant or lactating women
+Pregnant or lactating
+Pregnant or lactating females
+Pregnant or lactating women.
+Must not be breastfeeding/lactating.
+Subject who is pregnant or lactating.
+Women who are pregnant or lactating
+Pregnant or lactating women
+Lactating or pregnant women
+Pregnant or lactating females
+Lactating or pregnant women
+Not pregnant or lactating
+Pregnant or lactating females
+Lactating woman
+Pregnant or lactating
+EXCLUSION - TREATMENT: Pregnant or lactating
+Pregnant and/or lactating women
+Female patients who are lactating or pregnant
+Women who are pregnant or lactating
+Pregnant, likely to become pregnant, or lactating women
+EXCLUSION - INFUSION: Pregnant or lactating
+Lactating or pregnant
+Lactating and pregnant women
+TREATMENT EXCLUSION: Pregnant or lactating
+Lactating or pregnant
+Lactating females and/or pregnant females
+Patients who are pregnant or lactating
+Patient is pregnant or lactating
+Pregnant women and lactating women
+The patient is pregnant or lactating.
+Pregnant or lactating females.
+Pregnant or lactating women
+Pregnant and/or lactating women
+Women that are pregnant or lactating are excluded from this study
+Pregnant or lactating
+Pregnant or lactating
+Pregnant or lactating
+Pregnant or lactating.
+Pregnant females; (lactating females must agree not to breast feed while taking ibrutinib)
+Pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating patients
+Pregnant or lactating
+Pregnant or lactating
+Women who are pregnant or lactating
+EXCLUSION - TREATMENT: Pregnant or lactating
+Pregnant or lactating females
+If they are pregnant or lactating
+Is a pregnant or lactating female
+Pregnant or lactating females; women of childbearing age will agree to use contraception during the protocol
+Women who are pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating, or intending to become pregnant during the study
+Pregnant or lactating, or intending to become pregnant during the study
+Patients must not be pregnant or lactating
+Female subject who is lactating/breastfeeding.
+Is lactating or pregnant as confirmed by pregnancy tests performed within 7 days before enrollment
+Patients who are pregnant or lactating, plan to get pregnant, or have a positive serum pregnancy test prior to randomization.
+Non-pregnant and non-lactating
+Women who are pregnant or lactating.
+Women who are pregnant or lactating
+Pregnant or lactating, or intending to become pregnant during or within 5 months after the last dose of study treatment Exclusion Criteria Related to Atezolizumab:
+Pregnant or lactating women
+Patient is pregnant or lactating and does not agree to stop breastfeeding.
+Pregnant and/or lactating women
+Pregnant, lactating, or not using adequate contraception.
+Pregnant or lactating female.
+Pregnant or lactating females
+Pregnancy, lactating or breastfeeding women
+Pregnant or lactating females
+Patients who are pregnant or lactating.
+Pregnant and/or lactating women
+Pregnant or lactating females
+Women who are pregnant or lactating
+Pregnant or lactating females
+Pregnant or lactating women
+Pregnant women or lactating women who are breastfeeding are excluded from this study
+Patients who are pregnant, lactating, or breastfeeding
+Pregnant and lactating women
+Subjects who are pregnant or are lactating
+Pregnant and lactating women are excluded
+Currently pregnant, lactating or breastfeeding.
+Lactating women are excluding from the study
+Females who are pregnant or lactating
+Pregnant and lactating women are excluded from this study.
+Women who are pregnant or lactating
+Women who are pregnant or lactating
+Pregnant or lactating women
+Pregnancy and/or lactating.
+Female subjects who are pregnant or lactating, including females with a positive pregnancy test at screening.
+Patients who are pregnant or lactating
+Pregnant or lactating female
+Pregnant or lactating
+Pregnant or lactating patients
+Lactating or pregnant
+Pregnant or lactating patients
+Pregnant or lactating women
+Pregnant or lactating female
+Women who are pregnant, lactating or expecting to conceive
+Is pregnant or lactating
+Women who are pregnant or lactating.
+If female, the patient is pregnant or lactating.
+Pregnant or lactating women
+Female only: pregnant or lactating
+Women who are pregnant or lactating
+DONOR: Pregnant or lactating
+Pregnant or lactating, or intending to become pregnant during the study
+Pregnant or lactating women
+Pregnant or lactating females
+Lactating or pregnant
+Lactating female
+Pregnant or lactating
+Pregnant or lactating females
+Pregnant or lactating individuals.
+Lactating or pregnant
+Pregnant or lactating women
+Patients may not be pregnant or lactating at study registration
+Females who are pregnant, lactating, or intend to become pregnant during their participation in the study
+Pregnant or lactating subjects
+Pregnant and/or lactating women
+Be pregnant or lactating
+PART 1 EXCLUSION CRITERIA: Pregnant or lactating females
+PART 2 GROUP 1 EXCLUSION CRITERIA: Pregnant or lactating females
+PART 2 GROUP 2A EXCLUSION CRITERIA: Pregnant or lactating females
+PART 2 GROUP 3 EXCLUSION CRITERIA: Pregnant or lactating females
+Pregnant or lactating women are excluded from the study
+Pregnant or lactating women are excluded from this study
+Female patients who are pregnant or lactating
+PRIOR TO CELL PROCUREMENT: Pregnant or lactating
+PRIOR TO LYMPHODEPLETION: Pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating individuals.
+Females who are pregnant, lactating, or intend to become pregnant during the participation of the study
+Pregnant or lactating females
+Pregnant or lactating female
+Women that are pregnant or lactating
+Pregnant or lactating women
+Women who are pregnant or lactating;
+Subjects must not be pregnant or lactating
+Pregnant or lactating
+Pregnant or lactating
+Subject that is pregnancy or lactating
+Females who are pregnant or lactating
+Patients who are pregnant or lactating.
+Females who are pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating females
+Pregnant or lactating females
+Patients must not be pregnant of lactating
+Lactating females
+Female subject who is lactating or pregnant
+Pregnant or lactating women
+Pregnant or lactating woman
+Pregnant or lactating women
+AT THE TIME OF INFUSION: Pregnant or lactating
+Pregnant or lactating
+DONOR: Females must not be pregnant or lactating
+Female subject is pregnant or lactating
+Pregnant and lactating women
+Patients who are pregnant or lactating
+Lactating females
+Females who are pregnant or lactating
+Patients who are pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating women
+Lactating females
+Pregnant or lactating female
+Patients who are pregnant or lactating
+Pregnant or lactating patients
+Pregnant or lactating women
+Pregnant women and women who are lactating
+Pregnant or lactating individuals.
+Lactating females
+Female patients who are pregnant or lactating
+Pregnant and lactating women are excluded from this study
+Pregnant and lactating women
+Patients who are pregnant or lactating
+Pregnant and lactating women
+Pregnant or lactating patients
+Pregnant or lactating female.
+Pregnant or lactating patients
+Patients who are pregnant or lactating.
+Patients in pregnant or lactating
+Pregnant or lactating females
+No pregnant or lactating females
+Pregnant or lactating
+Women who are pregnant or lactating
+Pregnant or lactating
+Patients who are pregnant or lactating are NOT eligible for participation
+Patients must not be pregnant or lactating females.
+Lactating females
+Patient is pregnant, lactating, or planning on being pregnant within the next 6 months
+RECIPIENT: Pregnant or lactating
+Pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant or lactating females
+Patients who are pregnant and/or lactating
+Pregnant or lactating females
+Pregnant or lactating.
+Lactating females
+Pregnant or lactating females
+Pregnant or lactating female
+Pregnant or lactating female
+COHORTS 1 AND 2: HEALTHY VOLUNTEERS: Pregnant or lactating
+Pregnant or lactating women
+Lactating or pregnant females
+Pregnant or lactating women are excluded from this study
+Pregnant or lactating women.
+Pregnant or lactating women
+Patients who are pregnant or lactating
+Pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant females; (lactating females must agree not to breast feed while taking the study medications)
+Lactating women are excluded from study participation.
+Lactating or pregnant
+Pregnant or lactating women
+Pregnant or lactating
+Pregnant or lactating; women should not breast feed during the interval from study entry to one\r\nyear post-transplant
+Pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating females
+Women who are pregnant or lactating due to potential exposure of the fetus to RT and unknown effects of RT to lactating females
+Pregnant or lactating
+DONOR: Pregnant or lactating women are not eligible
+Pregnant and lactating females will be excluded
+Pregnant or lactating female
+Patients who are pregnant or lactating
+Pregnant or lactating female
+Female patients who are pregnant or lactating are not eligible to receive treatment but can be followed for natural history
+Pregnant or lactating females
+Lactating females
+Patients who are pregnant or lactating;
+Females who are pregnant, lactating, or breastfeeding, or who plan to become pregnant during the study
+Female subject who is pregnant or lactating.
+Pregnant and lactating women
+Females who are pregnant or lactating or plan to become pregnant during the course of this study.
+pregnant or lactating
+Pregnant or Lactating.
+Pregnant and/or lactating women are excluded
+Patients who are pregnant or lactating
+Is a pregnant or lactating female.
+Patients who are pregnant and/or lactating are NOT eligible for participation
+Women who are pregnant or lactating.
+Women who are pregnant or lactating are NOT eligible
+Pregnant or lactating
+Pregnant, lactating, or not using adequate contraception
+Pregnant or lactating or planning pregnancy during treatment period.
+Pregnant or lactating women.
+Pregnant, lactating or not using adequate contraception.
+Pregnant or lactating females
+Lactating or pregnant
+Pregnant or lactating female.
+Is pregnant or lactating.
+Pregnant or lactating patients
+Subjects who are pregnant or lactating;
+Non-pregnant and non-lactating.
+If they are pregnant or lactating
+Women who are pregnant or lactating or intending to become pregnant before, during, or within 3 months after the last dose of study drug.
+Lactating females.
+Pregnant or lactating female.
+Pregnant or lactating females
+Lactating females
+Who are pregnant and/or lactating
+Pregnant or lactating women
+Women who are pregnant or lactating.
+Pregnant or lactating patients
+Pregnant or lactating females
+Lactating females
+Pregnant or lactating patients
+Lactating women
+Pregnant or lactating
+Pregnant or lactating females
+Pregnant or lactating
+Pregnant or lactating, or intending to become pregnant during the study
+Subject is pregnant or is lactating
+Subject is pregnant or lactating
+Pregnant or lactating, or intending to become pregnant during the study
+Lactating or pregnant females
+Lactating females are not eligible
+The recipient is pregnant or a lactating female
+DONOR: Pregnant or lactating females
+Pregnant or lactating women are ineligible
+Pregnant or lactating females who chose to breast feed
+Pregnant or lactating patients
+Pregnant or lactating women
+Pregnant or lactating women
+Patients who are pregnant or lactating
+Subject is pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant or lactating females
+Pregnant or lactating women
+Lactating or pregnant females
+Patients who are pregnant or lactating
+Women who are currently lactating
+Women who are pregnant or lactating
+Pregnant and lactating women are excluded from this study
+Lactating females
+Lactating or pregnant female.
+Pregnant or lactating women
+Lactating or pregnant females
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant and/or lactating women are not eligible to participate in this study
+Pregnant or lactating
+Pregnant or lactating
+Women who are pregnant or lactating or refuse to commit to use contraception anytime during the study
+Participant is pregnant or lactating.
+Pregnant or lactating women
+Subject has had prior treatment with lenalidomide. 7. Subject is pregnant or lactating.
+Pregnant or lactating female patients.
+Patients who are pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating females.
+The participant is pregnant prior to randomization or lactating.
+Subject is pregnant or lactating
+Women who are pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating women
+Women who are pregnant or lactating
+Women who are pregnant or lactating
+Pregnant or lactating women
+Is a pregnant or lactating female.
+Pregnant or lactating women
+Female subject who is pregnant or lactating
+Women who are pregnant or lactating.
+Pregnant and lactating women
+Pregnant or lactating
+Females who are pregnant or lactating.
+Matched Related Donor: Pregnant or lactating females
+Unrelated Donor: Pregnant or lactating females
+Pregnant or lactating women
+Pregnant or lactating or intending to become pregnant during the study
+Women who are pregnant or lactating
+Pregnant or lactating (breastfeeding) females.
+Male or non-pregnant, non-lactating female
+Pregnant or lactating female
+Women who are pregnant or lactating.
+Pregnant or lactating women
+Female patients who are pregnant or lactating.
+Participants who are pregnant or lactating
+DONOR: Pregnant or lactating females
+Lactating or pregnant subjects
+Pregnant or lactating women
+Pregnant or lactating females
+Lactating or pregnant
+Pregnant or lactating.
+Women who are pregnant or lactating or intending to become pregnant during the study
+Lactating or pregnant
+Pregnant or lactating women
+Not pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating females
+Pregnant or lactating women
+Male or non-pregnant and non-lactating female
+Are pregnant or lactating.
+Pregnant or lactating women
+Pregnant or lactating women
+Women who are pregnant or lactating
+Pregnant or lactating women
+Lactating female.
+Pregnant or lactating females
+Women who are pregnant or lactating Dose-Escalation Portion of the Study:
+Is a pregnant or lactating female
+Pregnant or lactating females.
+Women who are pregnant or lactating
+Pregnant or lactating women
+Women who are pregnant or lactating
+Pregnant or lactating women.
+Pregnant or lactating women
+Pregnant or lactating
+Participant is pregnant or lactating
+Lactating females
+Pregnant or lactating women
+Female: pregnant or lactating
+Pregnant, likely to become pregnant, or lactating women (where pregnancy is defined as the state of a female after conception and until the termination of gestation)
+Pregnant or lactating women
+Pregnant or lactating women are excluded from this study
+No pregnant or lactating women
+Participants who are pregnant or lactating
+Women who are lactating or breastfeeding
+Female patients who are lactating, breastfeeding, or pregnant
+Women who are pregnant or lactating
+Women who are pregnant or lactating.
+Women who are pregnant or lactating
+Women who are pregnant or lactating
+Pregnant or lactating females
+Women who are pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant or lactating
+Women who are pregnant or lactating are not eligible for study treatment
+Lactating or pregnant women
+Females who are pregnant or lactating
+Lactating or pregnant subjects
+Pregnant or lactating females
+Pregnant or lactating female
+Pregnant or lactating females
+Lactating or pregnant women
+Pregnant or lactating females
+Pregnant and lactating women
+Pregnant or lactating women
+Women who are pregnant or are lactating
+Pregnant or lactating females
+Pregnant or lactating females
+Lactating female
+Women who are pregnant or lactating
+Patients who are pregnant or lactating
+Patients who are pregnant or lactating
+Women who are pregnant or lactating
+Pregnant or lactating females
+Patients who are pregnant or lactating
+Pregnant and lactating women
+Currently pregnant or lactating
+Subjects who are pregnant or lactating or who are planning to become pregnant during the course of the study are excluded.
+Pregnant or lactating females
+Pregnant or lactating women
+AT THE TIME OF INFUSION: Pregnant or lactating
+Pregnant or lactating women are excluded from this study
+Pregnant or lactating women
+Lactating or pregnant.
+No pregnant or lactating females
+Pregnant or lactating females
+Pregnant and lactating women
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant, lactating or actively breastfeeding female subjects
+Pregnant or lactating women.
+Pregnant or lactating females.
+Pregnant or lactating females
+Pregnant or lactating females
+Female patients who are pregnant or lactating
+Subjects who are pregnant or lactating.
+Women who are pregnant or lactating
+Pregnant or lactating women
+Pregnancy and/or lactating
+Pregnant or lactating women
+Female patients who are lactating or pregnant
+Lactating females
+Pregnant or lactating females
+Pregnant or lactating patients
+Lactating females
+Pregnant or lactating females
+Patient is pregnant, lactating, or breastfeeding
+Pregnant or lactating women
+Pregnant or lactating women
+The patient, if female, is pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant and lactating women are excluded from the study
+Pregnant or lactating women
+Women who are pregnant or lactating are not eligible for study treatment
+Pregnant or lactating females
+Pregnant or lactating female
+Women who are lactating;
+A pregnant or lactating woman.
+Pregnant or lactating patients
+Women who are pregnant or lactating
+Pregnant women and lactating women
+Pregnant or lactating women
+Pregnant or lactating patients
+Pregnant or lactating women
+Pregnant or lactating.
+If female, is lactating.
+Pregnant or lactating women
+Pregnant or lactating female
+Patient is pregnant or lactating
+Pregnant or breastfeeding women; (lactating women must agree not to breast feed while taking 5-azacitidine)
+Lactating female or female who becomes pregnant prior to transition to this study.
+Pregnant or lactating females
+DONOR: Female donors must not be pregnant or lactating
+If female, neither pregnant nor lactating.
+Pregnant or lactating women
+Pregnant or lactating women
+Female patients who are pregnant or lactating
+Male or non-pregnant, non-lactating female patients
+Pregnant or lactating
+Women who are pregnant or lactating
+Females who are pregnant or lactating
+DONOR: Pregnant or lactating females
+Lactating women
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant and lactating women
+Pregnant or lactating female.
+Patients cannot be lactating
+Pregnant or lactating women
+Pregnant or lactating women
+Females who are pregnant or lactating
+Pregnant or lactating female
+Pregnancy or lactating females
+Pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating women
+EXPANSION COHORT ONLY: Female subjects who are pregnant or lactating are not eligible to participate in this study
+Patients who are pregnant or lactating
+Pregnant or lactating females.
+Females who are pregnant or lactating.
+Pregnant or lactating women
+Lactating or pregnant
+Pregnant or lactating females
+Pregnant or lactating female;
+Pregnant or lactating women
+Pregnant or lactating women
+Women who are pregnant or lactating
+Women who are pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating females.
+Pregnant or lactating women
+Pregnant or lactating
+Pregnant or lactating females.
+Pregnant or lactating patients
+Pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating women
+Lactating female
+Female subject is pregnant or lactating
+If female, participant is pregnant or lactating at the time of enrollment, or has plans to become pregnant during the study
+Women who are pregnant or lactating
+Women who are lactating
+Patients who are pregnant or lactating
+Women who are pregnant or lactating
+Pregnant or lactating women
+Lactating or pregnant.
+Patients who are pregnant or lactating
+Pregnant and lactating women are excluded from the study
+Pregnant or lactating
+Is a pregnant or lactating female.
+Women who are pregnant or lactating
+Lactating females
+Pregnant or lactating female
+Pregnant or lactating female.
+Pregnant or lactating pts
+DONOR: not pregnant or lactating
+Pregnant or lactating
+Pregnant or lactating female.
+Patients who are pregnant or lactating
+Pregnant or lactating female
+Pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant or lactating
+Pregnant or lactating females
+Pregnant or lactating females
+Pregnant and/or lactating women will be excluded
+Patients who are pregnant or lactating or not practicing adequate contraception
+Pregnant or lactating women
+DONOR: Not pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant or lactating females
+Women who are pregnant or lactating
+Pregnant or lactating women
+Patients who are pregnant or lactating are not eligible
+Male or non-pregnant, non-lactating, females
+Pregnant or lactating women
+Patient is a female who is pregnant, lactating, or is planning a pregnancy during study participation, or in the follow-up period.
+Pregnant or lactating women
+Female subjects who are pregnant or lactating at Screening, or plan to become pregnant while on study or within 6 months after the last dose of study drug
+Pregnant or lactating women
+Pregnant or lactating subjects.
+Pregnant or lactating female.
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant or lactating females
+Woman who is pregnant or lactating
+Women who are pregnant or lactating
+Pregnant or lactating females
+Patients who are pregnant or lactating
+Participant is pregnant or lactating
+Pregnant (positive pregnancy test) or lactating
+Suspected pregnancy, pregnant or lactating females
+Women who are pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating women
+Females who are pregnant or lactating
+Women who are pregnant or lactating
+Women who are pregnant or lactating
+Pregnant or lactating females
+Pregnant, lactating or breastfeeding females
+Lactating females or pregnant females
+Is a pregnant or lactating female
+Pregnant or lactating women
+Pregnant or lactating females
+Female patients who are pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating female
+Women who are pregnant or lactating
+Female patients who are lactating or pregnant
+Subject is pregnant or lactating.
+Female patients who are pregnant or lactating and breastfeeding
+Pregnant or lactating females
+Pregnant or lactating females
+Lactating female
+Pregnant, lactating or planning to become pregnant
+Women who are pregnant (confirmed by positive pregnancy test) or lactating
+Pregnant or lactating females
+Female subjects who are pregnant or lactating
+Lactating or pregnant female.
+Pregnant or lactating women
+Pregnant or lactating women
+Female patients who are pregnant or lactating.
+Pregnant or lactating females
+Pregnant or lactating women
+Pregnant or lactating women
+Patients who are pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant or lactating women
+Pregnant or lactating women
+Subject is a lactating or pregnant female.
+Female patients who are lactating or pregnant
+If female, pregnant or lactating
+Pregnant or lactating women
+Lactating women
+Are pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating women
+Women who are lactating/breastfeeding or planning to become pregnant during the duration of the study
+Pregnant or lactating females
+Patient is pregnant or lactating
+The participant is pregnant or lactating.
+Lactating women.
+Pregnant or lactating
+Pregnant or lactating female
+Pregnant or lactating females
+Pregnant or lactating female.
+For female patients: the patient is pregnant or lactating.
+Currently lactating.
+Women who are pregnant or lactating (cohort 1)
+Women who are pregnant or lactating (Cohort 1)
+Women who are pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating
+Pregnant and lactating women are excluded from this study
+Women who are pregnant or lactating
+Women who are pregnant or lactating
+Pregnant or lactating females.
+Is a pregnant or lactating female.
+The participant is pregnant or lactating
+Pregnant or lactating women
+Any patients with allergy to the drug; and any pregnant female or lactating.
+For female patients: the patient is pregnant or lactating.
+Pregnant or lactating females.
+Pregnant or lactating women
+Patients who are pregnant or lactating
+Pregnant or lactating women
+Pregnant and lactating women
+Pregnant and/or lactating women will be excluded
+Patients who are pregnant or lactating
+Pregnant or lactating females
+Pregnant or lactating women or woman of childbearing potential
+Pregnant or lactating women
+Self-report of being pregnant or lactating
+Pregnant or lactating women
+Subject is pregnant or lactating
+Patients who are pregnant or lactating
+Females who are pregnant or lactating
+Pregnant or lactating women
+Pregnant or lactating females are excluded from enrollment on this trial
+Pregnant or lactating women
+Pregnant or lactating
+Pregnant, wanting to become pregnant or lactating women
+Pregnant or lactating women; childbearing age women are not on birth control
+Females who are pregnant or lactating
+Pregnant or lactating women; childbearing age women are not on birth control
+Lactating women
+Women who are pregnant or lactating
+Lactating or pregnant women
+Female subjects of childbearing potential must not be pregnant or lactating at screening
+Pregnant or lactating women
+Lactating or pregnant
+Lactating or pregnant
+Patients who are pregnant or lactating
+Women who are pregnant and/or lactating.
+Female subjects that are pregnant or lactating.
+Pregnant or lactating
+Pregnant or lactating women
+Treatment with systemic immunosuppressive medications - Pregnant or lactating women
+Pregnant women/lactating mothers
+Pregnant or lactating women (to be obtained via subject report only)
+The patient is pregnant or lactating
+Female patients who are pregnant or lactating at the baseline/screening visit
+The subject is known or suspected to be pregnant or lactating
+Women who are pregnant or lactating
+Pregnant or lactating
+No patients known to be pregnant or lactating
+Women of childbearing potential must not be known to be pregnant or lactating
+Pregnant and/or lactating within 1 year prior to screening breast MRI
+Patients pregnant or lactating
+Must be non-pregnant and non-lactating for at least one year prior to pre-registration
+Patient is pregnant or lactating and does not agree to stop breastfeeding.
+Pregnant or lactating women
+Lactating female patient.
+Female patients who are lactating or pregnant
+Pregnant or lactating females
+Pregnant or lactating
+Are planning to conceive or are currently pregnant or lactating
+Lactating
+Pregnant or lactating females
+Pregnant or lactating women
+Subjects who are pregnant and/or lactating are not eligible
+Pregnant or lactating women
+Pregnant or lactating female.
+Pregnant or lactating female patients
+Pregnant or lactating women
+Women who are pregnant, planning pregnancy within the next year, or lactating/breastfeeding
+Female patients who are lactating or pregnant
+Female patients who are lactating or pregnant
+Pregnant or lactating women
+Not pregnant or lactating and does not intend to become pregnant during the study
+Pregnant or lactating
+Pregnant or lactating female.
+Women who are pregnant or lactating are excluded from the study
+Patients who are pregnant or lactating
+The patient is pregnant or lactating
+Subjects who are pregnant or lactating or who suspect they might be pregnant
+Pregnant or lactating females
+Subjects who are pregnant or lactating or who suspect they might be pregnant
+Subjects who are pregnant or lactating or who suspect they might be pregnant
+Patients who are or might be pregnant or lactating
+Women who are pregnant, possibly pregnant, or lactating
+Patient who is pregnant and/or lactating
+Pregnant or lactating women
+Subject is pregnant or lactating
+Non-pregnant and non-lactating
+Female participants of childbearing age must not be lactating
+Pregnant or lactating women are excluded from this study
+Not pregnant or not lactating
+Pregnant or lactating patients
+Pregnancy or lactating female
+Pregnant or lactating women
+Lactating women
+Pregnant or lactating female, a serum pregnancy test will be performed within 2 weeks or less before the date of the FCH PET/CT scan in all women capable of becoming pregnant
+Pregnant or lactating patients
+Patient is lactating (breastfeeding) or pregnant
+Participants who are pregnant, lactating, or who suspect they might be pregnant are not eligible
+Pregnant or lactating females
+Patients who are pregnant or lactating
+Pregnant or lactating
+Women of childbearing potential must not be pregnant or lactating
+Subjects who are pregnant or lactating
+Pregnant or lactating female
+Females who are pregnant or lactating or who intend to become pregnant during participation in the study are not eligible to participate.
+Pregnant or lactating women
+Female subjects who are pregnant or lactating
+Subjects who are pregnant or lactating or who suspect they might be pregnant
+Pregnant or lactating women
+The subject is pregnant or lactating.
+Subject is pregnant or lactating
+Females who are pregnant and/or lactating
+Pregnant or lactating women
+Patients who are pregnant or lactating
+Are women who are pregnant or lactating.
+Pregnant or lactating female
+women pregnant or lactating
+The patient is pregnant or lactating.
+Females who are lactating or pregnant.
+Female who is lactating/breastfeeding.
+Pregnant women or lactating women
+Pregnant or lactating, or intending to become pregnant during the study
+Pregnant or lactating females